PET-CT: A Case-Based Approach

Dedication\nPreface\nAcknowledgments\nContents\nContributors\n1: Normal Patterns and Artifacts\n	Bone Marrow Hyperplasia\n	Metal Implants\n	Pacemaker Artifact\n	Epidural Stimulator Artifact\n	Vascular Uptake [Aorta] and Bilateral Hip Joint with Peripheral Uptake: Inflammatory Degenerative Changes\n	Post-RFA Assessment Lesions\n	Post-RFA of Hepatic Lesion Photopenia (Absent Uptake) on PET Images on the Left Correlating with Low Attenuation Region on CT\n	Subclinical Aspiration\n	Postradiation Changes in the Mid Spine with Low Bone Mineral Density on CT and Photopenia (Absent Uptake) on PET\n	Thymic Hyperplasia Post Chemotherapy\n	Dextrocardia\n	Muscular Uptake Variations on PET/CT Scan\n	Radiation Myositis\n	Weight Lifting\n	Sit-Ups Prior to Injection\n	Tense, Cervical, and Intercostal Muscular Uptake\n	PET Uptake Secondary to Inflammatory Changes Post Subcutaneous Injections\n		Gluteal Subcutaneous Uptake, Postinjection Soft Tissue Changes on CT\n		Thigh Subcutaneous Uptake, Postinjection Soft Tissue Changes on CT\n	Attenuation Correction Artifact\n		Vertebroplasty Artifact, Increase Uptake on AC Images (Left) with no Uptake on NAC Images (Right)\n2: Lung Neoplasms\n	References\n3: Breast Neoplasms\n	References\n4: Esophageal and Gastric Neoplasms\n	Suggested Reading\n5: Hepatobiliary, Pancreas, Adrenal, Melanoma, and GIST\n	Suggested Reading\n6: Colon Neoplasms\n	Suggested Reading\n7: Gynecologic Neoplasms: Cervical, Ovarian, Vulvar, Uterine, and Endometrial Cancer\n	Cervical Cancer\n	Ovarian Cancer\n	Endometrial/Uterine Cancer\n	Vulvar Cancer\n	References\n8: Urologic Neoplasms: Prostate, Bladder, and Renal Cell Carcinoma\n	Prostate Cancer\n	Bladder Cancer\n	Renal Cell Carcinoma\n	References\n9: Lymphoma\n	References\n10: Musculoskeletal Neoplasms\n	Suggested Reading\n11: F-18 Fluoride Bone Scintigraphy\n	Prostate Cancer\n	Breast Cancer\n	Lung Cancer\n	Additional Benign Findings\n	References\n12: Neuroradiology: Neoplasms and Epilepsy\n	References\n13: Dementia\n	Suggested Reading\n14: Pediatric Imaging\n	Suggested Reading\n15: Myocardial Viability\n	FDG Viability Scintigraphy\n		Introduction\n		Overview\n		Technique\n	[18F]-FDG Cardiac Viability Imaging Protocol\n		Scheduling Considerations\n		Patient Preparation\n	Radiopharmaceutical Dosage\n	Clinical Imaging Procedure\n	Artifacts Associated with PET-CT Myocardial Perfusion Scintigraphy\n		Misregistration of PET and CT Transmission Data\n		Breast Attenuation Artifact\n	Attenuation Attributed to Large Region of Interest\n	Noncardiac Findings\n	Suggested Reading\n16: Granulomatous Diseases\n	References\n17: Newer Tracers\n	18F-AV-45 and 18F-FDG\n	64Cu-ATSM (64Cu-ATSM: Copper (II)-Diacetyl-­Bis(N4-Methylthiosemicarbazone) and 18F-FDG)\n	18F-MISO (18F-Fluoromisonidazole)\n	F-18 FLT\nIndex